Comment: Cigna, Humana have limited opportunities to reduce regulatory risk

Health insurers Cigna and Humana, which are reportedly contemplating a $140 billion merger, would have a hard time convincing antitrust regulators that any potential concerns with their deal could be resolved...

Already a subscriber? Click here to view full article